GlassScriptPhysician profile
Nicole E Mckenna
NPI 1447039722
$1,274.87
in general payments reported to CMS, 2019-2025
23 companies · $572 in 2025
The $572 reported for 2025 was more than what 79% of Acute Care (Nurse Practitioner) providers received nationally (typical 2025 total: $151).
See the full distribution for Acute Care (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $41.71 · 2024: $661 · 2025: $572.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,275.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,274.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Grifols USA, LLC | $201.07 | 2023-2025 | Prolastin-C Liquid |
| Boehringer Ingelheim Pharmaceuticals, INC. | $163.37 | 2023-2025 | Ofev, Jascayd |
| Genzyme Corporation | $105.94 | 2024 | |
| Verona Pharma, INC. | $89.29 | 2025 | Ohtuvayre |
| Astrazeneca Pharmaceuticals LP | $76.42 | 2024-2025 | Tezspire, Airsupra, Fasenra |
| Janssen Pharmaceuticals, INC | $70.54 | 2024 | Xarelto |
| Electromed, INC. | $65.16 | 2024-2025 | Smartvest |
| Regeneron Healthcare Solutions, INC. | $64.45 | 2024-2025 | Dupixent |
| Mylan Specialty L.P. | $48.51 | 2024 | Yupelri |
| Coaptech, INC. | $43.88 | 2024 | Puma System |
| La Jolla Pharmaceutical Company | $41.13 | 2024 | Giapreza |
| Baxter Healthcare | $38.31 | 2025 | Hillrom - Vest System Model 105 Home Care |
| Abiomed | $35.29 | 2025 | |
| Ucb, INC. | $34.80 | 2024 | Briviact |
| Vifor Pharma, INC. | $26.65 | 2024 | Veltassa |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Viatris Specialty LLC | $24.73 | 2025 | Yupelri |
| Shionogi INC | $24.52 | 2024 | Fetroja |
| Paratek Pharmaceuticals, INC. | $24.42 | 2025 | Nuzyra |
| Liquidia Technologies, INC. | $23.32 | 2025 | Yutrepia |
| Insmed, INC. | $21.52 | 2025 | Arikayce |
| Inogen, INC. | $18.37 | 2024 | |
| Scpharmaceuticals INC. | $17.83 | 2025 | |
| Philips North America LLC | $15.35 | 2025 | Vest Therapy Und |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nicole Mckenna listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.